SKI Market

Indian Indices

Nifty

25,898.55 140.55
(0.55%)

Sensex

84,818.13 426.86
( 0.51%)

Bank Nifty

59,209.85 249.45
( 0.42%)

Nifty IT

38,097.00 307.10
( 0.81%)

Global Indices

Nasdaq

48,074.52 493.22
(1.04%)

Dow Jones

6,906.36 44.85
(0.65%)

Hang Seng

50,166.54 -436.26
(-0.86%)

Nikkei 225

9,710.82 55.29
(0.57%)

Forex

USD-INR

89.93 -0.16
(-0.18%)

EUR-INR

104.64 -0.26
(-0.25%)

GBP-INR

119.76 -0.28
(-0.23%)

JPY-INR

0.58 0.00
(-0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

100.5174369

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

46.38

43899.88

EPS(TTM)

Face Value()

Div & Yield %

55.87

2.08

Back

Veedol Corporation consolidated net profit rises 18.32% in the September 2025 quarter

Nov 11,2025

Net profit of Veedol Corporation rose 18.32% to Rs 40.94 crore in the quarter ended September 2025 as against Rs 34.60 crore during the previous quarter ended September 2024. Sales rose 6.93% to Rs 509.23 crore in the quarter ended September 2025 as against Rs 476.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	509.23	476.22	7
OPM %	10.42	9.69	-
PBDT	63.40	54.38	17
PBT	55.25	46.08	20
NP	40.94	34.60	18

25,898.55 140.55 (0.55%)

84,818.13 426.86 ( 0.51%)

59,209.85 249.45 ( 0.42%)

38,097.00 307.10 ( 0.81%)

48,074.52 493.22 (1.04%)

6,906.36 44.85 (0.65%)

50,166.54 -436.26 (-0.86%)

9,710.82 55.29 (0.57%)

89.93 -0.16 (-0.18%)

104.64 -0.26 (-0.25%)

119.76 -0.28 (-0.23%)

0.58 0.00 (-0.73%)